Brain, Vol. 126, No. 4, 804-813,
April 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg072
Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1
Department of Neurology, University of Würzburg, Würzburg, Germany
Correspondence to: Rudolf Martini, Department of Neurology, Section of Developmental Neurobiology, University of Würzburg, Josef-Schneider-Strasse 11, D-97080 Würzburg, Germany E-mail: rudolf.martini{at}mail.uni-wuerzburg.de *These two authors contributed equally to this work.
Mice heterozygously deficient for myelin protein zero (P0) mimicking human CharcotMarieTooth (CMT) disease 1B show T-lymphocyte and macrophage upregulation in peripheral nerves, which aggravates and modulates the genetically mediated demyelinating neuropathy. In connexin32 (cx32)-deficient (cx32def) mice, which mimic the X-linked dominant form of CMT (CMTX), T-lymphocyte and macrophage numbers are also significantly elevated in peripheral nerves. To test the hypothesis that immune cells are indeed pathogenic in this model, we cross-bred cx32def mice with recombination activating gene-1 (RAG-1)-deficient mice, which lack mature T- and B-lymphocytes. In these immunoincompetent double mutants, the number of endoneurial macrophages was reduced. Furthermore, features indicative of myelin degeneration and axonopathic changes were mitigated in the RAG-1-deficient double mutants, whereas enlarged periaxonal Schwann cell collars, a hallmark specific for cx32-mutants, were not reduced. Since both cx32- and P0 deficiency lead to similar immunopathogenic processes, we conclude that immune-mediated demyelination may be a feature common to many CMT-like neuropathies independent of the genetic origin.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. W. Ip, A. Kroner, M. Bendszus, C. Leder, I. Kobsar, S. Fischer, H. Wiendl, K.-A. Nave, and R. Martini Immune Cells Contribute to Myelin Degeneration and Axonopathic Changes in Mice Overexpressing Proteolipid Protein in Oligodendrocytes J. Neurosci., August 2, 2006; 26(31): 8206 - 8216. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Scherer, Y.-T. Xu, A. Messing, K. Willecke, K. H. Fischbeck, and L. J. B. Jeng Transgenic Expression of Human Connexin32 in Myelinating Schwann Cells Prevents Demyelination in Connexin32-Null Mice J. Neurosci., February 9, 2005; 25(6): 1550 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Grohmann, W. Rossoll, I. Kobsar, B. Holtmann, S. Jablonka, C. Wessig, G. Stoltenburg-Didinger, U. Fischer, C. Hubner, R. Martini, et al. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1) Hum. Mol. Genet., September 15, 2004; 13(18): 2031 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Runker, I. Kobsar, T. Fink, G. Loers, T. Tilling, P. Putthoff, C. Wessig, R. Martini, and M. Schachner Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder J. Cell Biol., May 24, 2004; 165(4): 565 - 573. [Abstract] [Full Text] [PDF] |
||||


